Zimmer upgraded to Buy from Hold at Argus Argus upgraded Zimmer citing improving financial metrics, higher surgical volumes, and benefits from its upcoming launch of the Persona knee. Price target is $90.
BIOLASE CEO Jeffrey Nugent to step down, Harold Flynn appointed CEO BIOLASE (BIOL) announced that Harold Flynn Jr. will become president and CEO, effective July 13. The current president and CEO Jeffrey Nugent will step down at that time. Since 2007, Flynn has been president of Zimmer Dental, a manufacturer and provider of medical devices for the dental market. Zimmer Dental is a division of Zimmer Holdings (ZMH).